Testing drug compounds on ... explain why there is a 90% failure rate during clinical development. The low rate of success is one of the contributors to the high cost and the slow R&D process ...

Dr. David Hein, chair of the Department of Pharmacology and Toxicology at the University of Louisville, says a major reason for high prices is the steep cost of drug development. “Most of the ...

The global AI In Life science Analytics Market is projected to be valued at USD 1.9 billion in 2024 and reach USD 3.6 billion ...

With US President Donald Trump leaning towards implementing additional tariffs on the pharmaceutical sector, there is potential to disrupt drug development costs and drug prices, with any tariffs ...